One Turn Open the globe →

Health · Silver Spring, United States · United States of America ·

FDA adds eye risk warning to GLP-1 drugs

Reported by 3 outlets · first reported Nov 10, 1:43 PM ET

The FDA ordered makers of Ozempic, Wegovy and similar drugs to add warnings about NAION, a rare optic nerve condition that can cause blindness.

Why it matters

Millions use these drugs and should know the risk.

Background

They are used for diabetes and weight loss.

The story so far

  1. FDA adds eye risk warning to GLP-1 drugs
  2. FDA orders eye-risk warnings on GLP-1 drugs

Follow the whole story →

Sources

This summary was written automatically from the reporting linked above; follow the sources for the full story. How One Turn works.

See it on the globe →All of Nov 10's stories

More on health